Surefire Medical Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its line of Surefire angiographic catheters. Surefire Medical will launch these products in the United States later this year.

October 12, 2012 — Biotronik announced the start of the prospective multicenter PARCADIA study. The study aims to identify risk factors that can help predict appropriate ICD interventions in patients with ischemic cardiomyopathy who have received an ICD for primary prevention according to the current ESC (European Society of Cardiology) guidelines.


October 12, 2012 — Boston Scientific announced it has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus valve system in up to 120 patients with severe aortic valve disease.

October 12, 2012 — Estech, a provider of minimally invasive cardiac ablation devices, last month announced the market release of its Cobra Fusion ablation system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now